Sertoli-Leydig Cell Tumor with Concurrent Rhabdomyosarcoma: Three Case Reports and a Review of the Literature
Table 1
TMN and FIGO classifications for ovarian tumors [23, 24].
TMN
FIGO
Primary tumor (T)
T0
No evidence of primary tumor
T1
I
Tumor limited to the ovaries
T1a
IA
Tumor limited to one ovary; capsule intact, no tumor on ovarian surface; no malignant cells in ascites or peritoneal washings
T1b
IB
Tumor limited to both ovaries; capsules intact, no tumor on ovarian surface; no malignant cells in ascites or peritoneal washings
T1c
IC
Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, and malignant cells in ascites or peritoneal washings
T2
II
Tumor involves one or both ovaries with pelvic extension
T2a
IIA
Extension and/or implants on the uterus and/or tube(s); no malignant cells in ascites or peritoneal washings
T2b
IIB
Extension to and/or implants in other pelvic tissues; no malignant cells in ascites or peritoneal washings
T2c
IIC
Pelvic extension and/or implants (T2a or T2b) with malignant cells in ascites or peritoneal washings
T3
III
Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis
T3a
IIIA
Microscopic peritoneal metastasis beyond the pelvis (no macroscopic tumor)
T3b
IIIB
Macroscopic peritoneal metastasis beyond the pelvis 2 cm or less in greatest dimension
T3c
IIIC
Macroscopic peritoneal metastasis beyond the pelvis >2 cm in greatest dimension and/or regional lymph node metastasis
